SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-019951
Filing Date
2019-10-08
Accepted
2019-10-08 10:20:10
Documents
16
Period of Report
2019-10-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k100819_amagpharma.htm   iXBRL 8-K 41621
2 SETTLEMENT AGREEMENT, DATED OCTOBER 8, 2019, BY AND AMONG AMAG PHARMACEUTICALS, f8k100819ex10-1_amag.htm EX-10.1 113959
3 PRESS RELEASE REGARDING SETTLEMENT AGREEMENT DATED OCTOBER 8, 2019 f8k100819ex99-1_amag.htm EX-99.1 23779
4 GRAPHIC image_001.jpg GRAPHIC 4245
5 GRAPHIC eximg99_01.jpg GRAPHIC 9200
  Complete submission text file 0001213900-19-019951.txt   416024

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE amag-20191008.xsd EX-101.SCH 3182
7 XBRL LABEL FILE amag-20191008_lab.xml EX-101.LAB 34581
8 XBRL PRESENTATION FILE amag-20191008_pre.xml EX-101.PRE 22704
18 EXTRACTED XBRL INSTANCE DOCUMENT f8k100819_amagpharma_htm.xml XML 3629
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 6174983300
AMAG PHARMACEUTICALS, INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10865 | Film No.: 191141987
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences